Nanobac Pharmaceuticals Inc. declares publication in the International Journal of Nanomedicine research that scientists of the University of California San Francisco cooperating with Nanobac scientists at National Aeronautics and Space Administration (NASA) at Johnson Space Center have closed presenting that calcium repositories in the human kidney known as Randall’s Plaque might in fact be Calcifying [...]
Concord Hospital announced that his Urologic Care Center is now offering a program of kidney stones treatment and prevention. This program extends the centre of the kidney stones diagnosis and treatment to include a comprehensive program of prevention through the stone consultation diet, lifestyle changes and appropriate medical therapy.
“Kidney stones are among the most painful [...]
Mission Pharmacal, the specialty pharmaceutical private company that launched the technology behind scores for metabolic diseases of the kidney stones, has sold the rights to its range of diagnostics for kidney stone Quest Diagnostics Incorporated.
In line with diagnostic products include UroRisk (R) Profile of diagnosis, StoneRisk (R) Profile diagnosis, monitoring StoneTrack Diagnostic Test, StoneRisk (R), [...]
Continue reading about The New “Owner†of Gold Standard Kidney Stones Diagnostic Tests